Environmental Toxin Illness
Fresh Fit Consulting · Little Silver, NJ
Toxin exposure is one of the most underdiagnosed contributors to chronic illness. Mold mycotoxins, heavy metals, and tick-borne pathogens accumulate in the body over time and produce a wide range of symptoms including persistent fatigue, brain fog, joint pain, respiratory irritation, immune dysregulation, and neurological symptoms that do not respond to conventional treatment because the underlying exposure has not been identified.
The clinical challenge is that these presentations closely mimic other conditions. A patient with mold toxicity may be evaluated for autoimmune disease, thyroid dysfunction, or depression before the environmental cause is considered. Standard panels do not test for mycotoxins, heavy metals, or tick-borne co-infections, and most physicians are not trained to recognize or treat the clinical patterns they produce.
FFC is one of a small number of practices in Monmouth County equipped to evaluate and manage toxin-related illness using specialty testing and physician-guided treatment protocols.
Mold Toxicity and Mycotoxin Exposure
Mold toxicity is particularly prevalent in the Northeast where older building stock and moisture issues create conditions for sustained mold growth. Mycotoxins produced by mold accumulate in the body and drive persistent multi-system symptoms that standard workups consistently fail to explain. Patients with mold toxicity are frequently told their results are normal or treated for conditions that share the same symptom profile without resolution.
FFC uses urine mycotoxin panels to identify specific mold toxins present in the body at the time of testing, providing diagnostic clarity that standard testing cannot. HLA-DR genetic susceptibility testing identifies patients whose immune systems are genetically less equipped to clear biotoxins, explaining why some individuals develop significant illness from exposures that do not affect others in the same environment.
Relevant for: Persistent fatigue, brain fog, respiratory irritation, joint pain, immune dysregulation, neurological symptoms, history of water-damaged building exposure
Testing: Urine mycotoxin panel through RealTime Labs and Mosaic Diagnostics. HLA-DR genetic susceptibility testing. Metabolomix for organic acid markers reflecting toxin burden and cellular stress.
Heavy Metal Accumulation
Heavy metals including arsenic, lead, and mercury accumulate in tissue over time through dietary exposure, environmental contact, and occupational sources. Their effects are chronic and systemic, contributing to neurological symptoms, immune dysfunction, fatigue, and metabolic disruption that develop gradually and are rarely connected to their source in conventional evaluation.
Mercury warrants specific attention given its prevalence in seafood and dental amalgam and its neurotoxic effects at relatively low levels of accumulation. FFC uses the Quicksilver Scientific Mercury Tri-Test to differentiate between organic and inorganic mercury sources and assess the body's ability to clear mercury effectively, providing information that a standard heavy metal panel does not capture.
Relevant for: Neurological symptoms, cognitive decline, fatigue, immune dysfunction, metabolic disruption, history of significant seafood consumption or amalgam dental fillings
Testing: Urine heavy metal panel through ZRT Labs and Vibrant America. Quicksilver Scientific Mercury Tri-Test for comprehensive mercury source differentiation.
Tick-Borne Illness
Standard Lyme disease testing misses a significant portion of active and post-treatment infections because it relies on antibody detection methods with well-documented sensitivity limitations, particularly in early infection and chronic presentations. Patients with persistent symptoms following Lyme treatment, or with symptoms strongly suggestive of tick-borne illness and negative standard testing, frequently remain undiagnosed and inadequately treated.
Co-infections including Babesia, Bartonella, Ehrlichia, and Anaplasma are transmitted by the same ticks that carry Lyme and produce overlapping symptoms that significantly complicate the clinical picture when undetected. FFC uses specialty panels that screen for Lyme and co-infections using more sensitive detection methods than standard antibody testing.
Relevant for: Suspected Lyme disease, post-treatment Lyme symptoms, chronic fatigue with tick exposure history, neurological symptoms of unknown cause, immune dysregulation
Testing: IGeneX Lyme and tick-borne illness panel. Galaxy Diagnostics tick-borne illness panel.
Where to start
Given the complexity and variability of toxin-related presentations, the Two-Step Assessment is the appropriate starting point for most patients in this category. It gives Dr. Boesler the full clinical picture before recommending a testing or treatment direction, ensuring that the right specialty panels are ordered for each patient's specific situation. Learn more →
Patients who have already been evaluated and have a specific toxin exposure they want to test for may contact FFC directly to discuss whether individual functional testing is appropriate.